Durairaj Arjunan

ORCID: 0000-0001-5110-334X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pituitary Gland Disorders and Treatments
  • Diabetic Foot Ulcer Assessment and Management
  • Neuroendocrine Tumor Research Advances
  • Bone health and osteoporosis research
  • Mesenchymal stem cell research
  • Hematological disorders and diagnostics
  • Hypertrophic osteoarthropathy and related conditions
  • Pain Mechanisms and Treatments
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diverse Scientific Research Studies
  • Bone and Joint Diseases
  • Diet and metabolism studies
  • Diabetes Treatment and Management
  • SARS-CoV-2 and COVID-19 Research
  • Venous Thromboembolism Diagnosis and Management
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Neuroblastoma Research and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Neurogenetic and Muscular Disorders Research
  • Connective tissue disorders research
  • COVID-19 Clinical Research Studies
  • Bone Metabolism and Diseases
  • Peripheral Artery Disease Management
  • Adrenal Hormones and Disorders

Post Graduate Institute of Medical Education and Research
2018-2025

Abstract Prolactinomas are the most common functional pituitary tumor and typically managed with dopamine agonists such as bromocriptine or cabergoline. Although these agents generally well tolerated effective in reducing prolactin levels often size, they have been implicated rare but serious fibrotic complications, including interstitial lung disease (ILD). We describe a 65-year-old man longstanding prolactinoma who received cumulative high-dose cabergoline therapy over several decades....

10.1210/jcemcr/luaf067 article EN cc-by JCEM Case Reports 2025-03-27

Type 2 diabetes mellitus has traditionally been considered a lifelong disease, with treatment focused on glycaemic control and complication prevention. Emerging evidence suggests that targeting glucolipotoxicity insulin resistance may restore beta-cell function, potentially leading to remission. This study aimed evaluate the feasibility of achieving remission through pharmacotherapy by promoting weight loss maintaining strict over 3-month period. is single-centre, open-label, randomised...

10.4103/ijem.ijem_356_24 article EN cc-by-nc-sa Indian Journal of Endocrinology and Metabolism 2025-03-01

We report a case of 35-year-old woman with recurrent episodes hypoglycemia. Biochemical investigation was suggestive hyperinsulinemic hypoglycemia, and hence provisional diagnosis insulinoma made. Despite extensive using magnetic resonance imaging, endoscopic ultrasound,

10.1210/jcemcr/luae192 article EN cc-by-nc-nd JCEM Case Reports 2024-10-18

ABSTRACT Cushing’s syndrome (CS) is a state of glucocorticoid excess with its effect on all the systems body. Steroids are known to affect bone health, leading altered microarchitecture. Patients CS at increased risk for development fracture but as initial presentation relatively uncommon. Here, we describe 31-year-old female who presented pain in bilateral hip joint and was found have right neck femur. Though she did not classical features CS, had striae thigh region. On evaluation,...

10.4103/ijemcr.ijemcr_45_23 article EN IJEM Case Reports 2024-01-01

Introduction Charcot neuro-osteoarthropathy (CNO) occurs late in diabetes and may cause fracture, deformity, higher mortality. Diabetic kidney disease (DKD) affects bone metabolism contributes to However, there is no data on prevalence of CNO its outcomes with coexisting DKD (or chronic [CKD]). Methods To ascertain the CKD (pick or DKD) among patients delineate remission active subsequent lower extremity amputation all-cause mortality during prospective follow-up. Consecutive diabetic...

10.1177/15347346241265751 article EN The International Journal of Lower Extremity Wounds 2024-07-21
Coming Soon ...